Catalyst Pharmaceuticals (CPRX) Q2 2026 Earnings

May 11Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.33
0.39
0.44
0.5

Details

Expected EPS
0.475
Actual EPS
0.5
Surprise EPS
0.03
Surprise Percent
+5.26%

Description

⁨Catalyst Pharmaceuticals⁩ (⁦CPRX⁩) has reported earnings of ⁦0.5⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts